Michelle spent 4 years in the pharmaceutical Industry as a regulatory/investigative toxicologist, then joined the MHRA and is now a Senior Pharmaco-Toxicologist. Principally, this involves the assessment of nonclinical data for Clinical Trials and Marketing Authorisation applications and the...
Ms Michelle Beharry, Expert Scientific Assessor and Pharmaco Toxicologist, MHRA
Talia Biran has been Executive Director, Medical Affairs, Oncology at Lexicon since 2013.
Talia is a Global Medical Affairs leader who brings more than 20 years of divers experience in pharmaceutical industry, having worked in companies such as, Novartis, Merck and Janssen, with particular...
Dr Talia Biran, Medical Affairs Lead, Oncology, Lexicon Pharma
Dr. Burian is a Board-Certified Clinical Pharmacologist by State Chamber of Physicians of Hesse in Germany and American Board of Clinical Pharmacology. She is an accomplished life science professional with over 10 years’ experience in biopharmaceutical R&D and a proven record of scientific...
Dr Maria Burian, Associate Director, Early Clinical Science, Grunenthal
Mr Dirk Cerneus, Global Clinical Pharmacology Leader, Astellas Pharma
Stephan Chalon joined MMV (Geneva, Switzerland) in May 2014. As Medical Director-Clinical Pharmacology, he is the physician responsible for early drug development and clinical pharmacology supporting antimalarial projects from Discovery up to Phase2A/Proof of Concept. Stephan did his medical...
Dr Stephan Chalon, Medical Director, Clinical Pharmacology, Medicines for Malaria Venture
Dr John Connell, Chief Research and Development Officer, MAC Clinical Research
Dr. Elizabeth de Lange is Head of Translational Pharmacology of the Leiden Academic Center for Drug Research (LACDR). Her ultimate aim is to contribute to the scientific basis for the prediction of human drug effects by translational pharmacokinetic -pharmacodynamic model development on the basis...
Dr Elizabeth De Lange, Head of Division of Pharmacology, Leiden Amsterdam Center for Drug Research LACDR
Dr Peter Dewland, Senior Director Early Phase Research, M.A.C. Clinical Research
Executive Medical Director/Director Respiratory & Allergy at QPS-NL
• Board-certified pulmonologist – clinical pharmacologist
• Certified Principle Investigator
Current Positions/Affiliations
• Guest Professor Respiratory Allergy Research: Skane University, Dept Respiratory Medicine &...
Zuzana Diamant, MD PhD Professor, Director Respiratory & Allergy, QPS LLC
Ms Corina Dota, Centre Director, AstraZeneca
Dr Domingo Gargallo Viola, Head of Pharmacology & Safety, Grupo Ferrer
Professor Niels Grabe, Director, Tissue Imaging and Analysis Center, University of Heidelberg Medical Center
Uwe Gudat received his medical degree from the University of Marburg, Germany. He is licensed in internal medicine and diabetology as a sub-speciality, training under Michael Berger in Düsseldorf Germany. Uwe Gudat joined the pharmaceutical industry in 1995 with Eli Lilly and since then has held...
Dr Uwe Gudat, Head of Safety, Biosimilars, Merck
Dr. Joos joined 1998 the NMI at the University of Tuebingen heading the department of biochemistry. Since 2013 he is the deputy managing director. His research is focused on miniaturized multiplexed immunoassays for biomarker research and diagnostic applications. Dr. Joos studied Biochemistry at...
Dr Thomas Joos, Deputy Managing Director, NMI Natural and Medical Sciences Institute at the University of Tuebingen
Muna obtained her Master’s degree in Clinical Research Management from the Cranfield University in Cranfield, United Kingdom. Muna looks back at over 20 years of experience working in the Pharmaceutical industry, at both Contract Research Organisations and the Pharma setting. Her know how includes...
Muna Kugler, Associate Director, Group Leader, Actelion
Ms Eleni Lagkadinou, Early Clinical Leader in Experimental Medicine Oncology and Global Drug Discovery, Bayer HealthCare
Mr Gezim Lahu, Senior Director and Global Head of Pharmacometrics, Takeda Pharmaceuticals
Johan Luthman is VP Neuroscience Clinical Development, Eisai Pharmaceuticals, where he is engaged in clinical development programs, primarily in the area of Alzheimer’s disease. Before joining Eisai, Johan was Senior Program Leader for Early Development Neuroscience & Ophthalmology at Merck...
Dr Johan Luthman, Vice President Neuroscience Clinical Development, Eisai Medical Research
Dr Derick Mitchell, CEO, Ipposi
Mr Mickael Montembault, Clinical Program Lead - Clinical Pharmacology Science & Study Operations (CPSSO), GSK
Dr. Pages is a Professor of Immunology at University Paris Descartes Medical School. He is responsible for the immunomonitoring platform of the Laboratory of Immunology in the Hopital Européen Georges Pompidou, Paris (HEGP), France. Current Research position Creation of a research group that is...
Professor franck pages, Professor (MD, PHD), Hopital Europeen Georges Pompidou
Dr. Stefano Persiani is currently Director of Translational Sciences at Rottapharm Biotech, Italy. After graduation at the University of Milan, and a one-year scholarship at the National Cancer Institute of Milan, he obtained a Postdoctoral Fellowship from the University of Pittsburgh, School of...
Dr Stefano Persiani, Director Of Translational Sciences & Pharmacokinetics, Rottapharm Biotech
Dr Solen Pichereau, PKPD Preclinical Modeler - Translational Medicine, Novartis
Dr Carmen Prenn-Gologranc, Clinical Research Scientist, AXON Neuroscience
Ms Monica Simeoni, Director, Clinical Pharmacology Modelling & Simulation, G.S.K.
Tobias M Suiter, MD is an expert in Global Pharmaceutical/Biologics Industry and has more than 20 years of senior industry experience. He holds his expertise in global and regional medical affairs leadership, product and franchise launch strategies/tactics, implementation of global and regional...
Mr Tobias Suiter, Vice President of Medical Affairs, Pharming Group Nv
As Director, European Corporate Development, Dr. Aernout van Haarst plays a key role in supporting the growth of new services at Celerion. By leveraging his scientific and drug development expertise, Dr. Van Haarst is focused on identifying and building partnerships with specialist early phase...
Dr Aernout van Haarst, Director, European Corporate Development, Celerion
Dr Thijs van Iersel is a Doctor of Medicine with 20+ years of experience in clinical development. He trained in Clinical Pharmacology in both the UK and the Netherlands and currently serves as Senior Director of Science at PRA Health Sciences. Previously Dr van Iersel has worked as Resident in...
Mr Thijs Van Iersel, Senior Director of Science, PRA Health Sciences
Ms Barbara Voith, Head of Clinical Sciences Operations, Bayer Pharma Ag
Vlatka Vrdoljak, Development Project Leader, R&D, TEVA
Professor Neil Williams is Founder and Chief Scientific Officer of KWS BioTest Ltd. He was also Founder of Trident Pharmaceuticals Inc, and inventor of their novel T regulatory cell inducing therapy for inflammatory disease. His positions have included Professor of Immunology and Research Director ...
Professor Neil Williams, CSO, KWS BioTest
Dr Gerhard Zugmaier, Executive Medical Director Global Development, Amgen
